# Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer

> **NCT04250948** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 108 (actual)

## Conditions studied

- Gastric Cancer
- Locally Advanced Solid Tumor

## Interventions

- **DRUG:** JS001
- **DRUG:** Oxaliplatin
- **DRUG:** S1
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT04250948
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-12
- **Primary completion:** 2022-06-27
- **Final completion:** 2024-10-05
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2023-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04250948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04250948, "Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04250948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*